Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 285.00
+3.00 (1.06%)
Aug 27, 2026, 11:03 AM JST
Healios K.K. Revenue
Healios K.K. had revenue of 7.00M JPY in the quarter ending June 30, 2026, a decrease of -68.18%. This brings the company's revenue in the last twelve months to 59.00M, down -47.32% year-over-year. In the year 2025, Healios K.K. had annual revenue of 104.00M, down -81.43%.
Revenue (ttm)
59.00M
Revenue Growth
-47.32%
P/S Ratio
645.26
Revenue / Employee
786.67K
Employees
75
Market Cap
38.07B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 104.00M | -456.00M | -81.43% |
| Dec 31, 2024 | 560.00M | 439.00M | 362.81% |
| Dec 31, 2023 | 121.00M | 31.00M | 34.44% |
| Dec 31, 2022 | 90.00M | 49.00M | 119.51% |
| Dec 31, 2021 | 41.00M | 14.00M | 51.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| RaQualia Pharma | 3.90B |
| Heartseed | 3.03B |
| Japan Tissue Engineering | 2.52B |
| ReproCELL | 2.30B |
| AnGes | 962.00M |
| Cuorips | 128.00M |
| Renascience | 68.00M |